1.Preoperative administration effect of metronidazole, ceftriaxone sodium and their combination on stenotic index of jejunal anastomotic segment of dogs.
Rehan RAFIQUE ; Muhammad Nadeem ASI ; Muhammad SAQIB ; Muhammad Hammad HUSSAIN ; Awais Ur Rehman SIAL ; Aqsa MUSHTAQ
Korean Journal of Veterinary Research 2014;54(1):27-30
The jejunum is the longest part of the small intestine and its lumen is mainly involved in the absorption of the nutrients. The present study was conducted to evaluate the effects of metronidazole, ceftriaxoine sodium and their combination on the stenotic index of the end to end jujunal anastomotic site. To accomplish this, 20 healthy stray dogs were subjected to end to end jejunal ansastmosis. Dogs in Group A (control) underwent jejunal anstomosis with no antibiotic prophylaxis, while those in Group B received surgery and metronidazole alone at 50 mg/kg, those in Group C received ceftriaxone sodium intravenously at 30 mg/kg body weight prior to surgery and dogs in Group D were given metronidazole in combination with ceftriaxone sodium at 50 mg/kg and 30 mg/kg, respectively, 2 h before surgical intervention. No significant difference (p > 0.05) in the stenotic index was observed at 14 days after jejunal anastomosis. These findings indicate that prophylactic administration of metronidazole and ceftriaxone sodium alone or in combination had no significant effect on the stenotic index of the jejunum.
Absorption
;
Animals
;
Antibiotic Prophylaxis
;
Body Weight
;
Ceftriaxone*
;
Dogs*
;
Intestine, Small
;
Jejunum
;
Metronidazole*
;
Sodium
2.Intra-operative complications increase with successive number of cesarean sections: Myth or fact?.
Shumaila ZIA ; Muhammad RAFIQUE
Obstetrics & Gynecology Science 2014;57(3):187-192
OBJECTIVE: To determine whether complications related to surgery increase with increasing number of cesarean sections (CSs) in upper segment placenta. To compare the complications in urgent and elective high order (4-6) repeat CSs. METHODS: A retrospective analysis of 519 women who underwent repeat CS was performed from January to December 2012. Women were divided into 3 groups: group 1 with previous 3 CS (n=325), group 2 with previous 4 CS (n=139), and group 3 with previous > or =5 CS (n=55). RESULTS: Statistically significant differences (P < 0.001) were observed among 3 groups, regarding mean gravidity, type of CS, midline incision and bilateral tubal ligation performed. The risks of severe intra-peritoneal adhesions, thin out lower uterine segment and bladder injury were significantly increased (P < 0.001) with increasing number of CS deliveries. Only one cesarean hysterectomy was done in group 1 due to post partum hemorrhage. No significant differences were found in blood loss, duration of surgery, post operative hospital stay as well as birth weight and Apgar scores of newborns. The elective and emergency CS groups of high order repeat CS had no remarkable differences in operative, post operative complications and fetal outcome. CONCLUSION: Women with repeat CS are at increased risk of having multiple intra-operative surgical complications which increase with each subsequent CS. Pregnant women must be informed of the related risks which may affect counselling regarding possible tubal ligation.Women with repeat CS are at increased risk of having multiple intra-operative surgical complications which increase with each subsequent CS. Pregnant women must be informed of the related risks which may affect counselling regarding possible tubal ligation.
Birth Weight
;
Cesarean Section*
;
Emergencies
;
Female
;
Gravidity
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Infant, Newborn
;
Length of Stay
;
Placenta
;
Pregnancy
;
Pregnancy Outcome
;
Pregnant Women
;
Retrospective Studies
;
Sterilization, Tubal
;
Urinary Bladder
3. Advances in research on Zika virus
Amjad ALI ; Braira WAHID ; Shazia RAFIQUE ; Muhammad IDREES ; Muhammad IDREES
Asian Pacific Journal of Tropical Medicine 2017;10(4):321-331
Zika virus (ZIKV) is rapidly spreading across the America and its devastating outcomes for pregnant women and infants have driven this previously ignored pathogen into the limelight. Clinical manifestations are fever, joint pain or rash and conjunctivitis. Emergence of ZIKV started with a first outbreak in the Pacific area in 2007, a second large outbreak occurred in the Pacific in 2013/2014 and subsequently the virus spread in other Pacific islands. Threat of explosive global pandemic and severe clinical complications linked with the more immediate and recurrent epidemics necessitate the development of an effective vaccine. Several vaccine platforms such as DNA vaccine, recombinant subunit vaccine, ZIKV purified inactivated vaccine, and chimeric vaccines have shown potent efficacy in vitro and in vivo trials. Moreover, number of drugs such as Sofosbuvir, BCX4450, NITD008 and 7-DMA are ready to enter phase I clinical trial because of proven anti-ZIKV activity. Monoclonal based antibodies offer promise as an intervention effective for use in pregnant women. In this review, we describe the advances in research on ZIKV such as research strategies for the development of antiviral drugs & vaccines, molecular evolution, epidemiology emergence, neurological complications and other teratogenic outcomes as well as pathogenesis.
4. Zika: As an emergent epidemic
Braira WAHID ; Amjad ALI ; Shazia RAFIQUE ; Muhammad IDREES
Asian Pacific Journal of Tropical Medicine 2016;9(8):723-729
Zika virus is a new global threat for 2016 that has been swept to almost all Americas and is now posing serious threats to the entire globe. This deadly virus is playing havoc to unborn lives because of its reported association with upsurge of fetal deformation called microcephaly and neuropathic disorders including Guillain-Barré syndrome. Till today, there is no vaccine prospect, antiviral therapy or licensed medical countermeasures to curb the teratogenic outcomes of this destructive viral infection. Diagnosis, treatment, chronicity and pathogenesis are still vague and unsettled. Therefore, this review article addresses all the aspects related to this disease to mitigate the explosive rise in Zika virus infection.
5. Asymptomatic dengue infection in adults of major cities of Pakistan
Ibrar RAFIQUE ; Muhammad Arif Nadeem SAQIB ; Muhammad Arif MUNIR ; Huma QURESHI ; Huma RIZWANULLAH ; Ijaz-ul-Haq TASEER ; Rizwan IQBAL ; Waqaruddin AHMED ; Tasleem AKHTAR
Asian Pacific Journal of Tropical Medicine 2017;10(10):1002-1006
Objective To determine the asymptomatic dengue infection in adults of Pakistani population. Methods This study was conducted in five major cities (Islamabad, Karachi, Lahore, Multan, and Peshawar) of Pakistan. A total of 5 230 adults aged 18 years and above without a history of dengue fever at any point in their life were enrolled from participating laboratories. Those who were confirmed for dengue previously were excluded. Of the total, 62.6% (n = 3 276) were male with an average age of 34.6 years. Participants were briefed about the objectives of the study, and written consent was obtained to perform dengue IgG test using enzyme linked immunosorbent assay. The brief information related to age, gender and area was also taken on proforma. Results Overall 32.3% (n = 1 691) was having asymptomatic dengue infection which was 67.5% (n = 756) in Karachi followed by 39.1% (n = 391) in Islamabad, 29.9% (n = 316) in Lahore and 21% (n = 228) in Peshawar and none from Multan. More males were affected with asymptomatic dengue infection than females. The asymptomatic dengue infection was significantly higher in different cities; however, there was no significant difference with respect to age groups. Conclusions The asymptomatic dengue infection is higher in cities i.e. Karachi, Islamabad and Lahore which are at risk of developing secondary dengue infections. There is a need of awareness among the public about secondary dengue infection.
6.A Longitudinal Survey for Genome-based Identification of SARS-CoV-2 in Sewage Water in Selected Lockdown Areas of Lahore City, Pakistan: A Potential Approach for Future Smart Lockdown Strategy.
Yaqub TAHIR ; Nawaz MUHAMMAD ; Z Shabbir MUHAMMAD ; A Ali MUHAMMAD ; Altaf IMRAN ; Raza SOHAIL ; A B Shabbir MUHAMMAD ; A Ashraf MUHAMMAD ; Z Aziz SYED ; Q Cheema SOHAIL ; B Shah MUHAMMAD ; Rafique SAIRA ; Hassan SOHAIL ; Sardar NAGEEN ; Mehmood ADNAN ; W Aziz MUHAMMAD ; Fazal SEHAR ; Hussain NADIR ; T Khan MUHAMMAD ; M Atique MUHAMMAD ; Asif ALI ; Anwar MUHAMMAD ; A Awan NABEEL ; U Younis MUHAMMAD ; A Bhattee MUHAMMAD ; Tahir ZARFISHAN ; Mukhtar NADIA ; Sarwar HUDA ; S Rana MAAZ ; Farooq OMAIR
Biomedical and Environmental Sciences 2021;34(9):729-733
7.Intercomparison of environmental gamma doses measured with A NaI (Tl) survey meter and thermoluminescent dosimeters (TLDs) in the Poonch division of Azad Kashmir, Pakistan.
Muhammad RAFIQUE ; Kimberlee J KEARFOTT ; Khalil AHMAD ; Jabeen AKHTER ; Abdul Razzaq KHAN ; Raja Azhar SAEED ; Saeed Ur RAHMAN ; Matiullah ; Muhammad Usman RAJPUT
Biomedical and Environmental Sciences 2014;27(12):969-972
This study presents the intercomparison of the outdoor environmental gamma dose rates measured using a NaI (Tl) based survey meter along with thermoluminescent dosimeters (TLDs) and estimation of excess lifetime cancer risk (ELCR), for the inhabitants of Poonch division of the Azad Kashmir, Pakistan. CaF2: Dy (TLD-200) card dosimeters were installed at height of 1 m from ground at fifteen different locations covering the entire Poonch division comprising of three districts. During three distinct two month time periods within the six month study period, all the installed dosimeters were exposed to outdoor environmental gamma radiations, retrieved and read out at Radiation Dosimetry Laboratory, Health Physics Division, PINSTECH laboratory, Islamabad. The ambient outdoor gamma dose rate measurements were also taken with NaI (Tl) based portable radiometric instrument at 1 m above the ground. To estimate the annual gamma doses, NaI (Tl) based survey data were used for one complete year following the deployment of the dosimeters. The mean annual gamma dose rates measured by TLDs and survey meter were found as 1.47±0.10 and 0.862±0.003 mGy/y respectively. Taking into account a 29% outdoor occupancy factor, the annual average effective dose rate for individuals was estimated as 0.298±0.04 and 0.175±0.03 mSv/y by TLDs and survey meter, respectively. For outdoor exposure, the ELCR was calculated from the TLD and survey meter measurements. The environmental outdoor average annual effective dose obtained in present study are less than the estimated world average terrestrial and cosmic gamma ray dose rate of 0.9 mSv/y reported in UNSCEAR 2000. The possible origins of gamma doses in the area and incompatibilities of results obtained from the two different measurement techniques are also discussed.
Gamma Rays
;
adverse effects
;
Humans
;
Neoplasms
;
etiology
;
Pakistan
;
Radiation Monitoring
;
instrumentation